Samsung Next invests in early-stage startups developing software, hardware, and services that deliver higher quality experiences and better outcomes at lower costs, with a strong emphasis on non-clinical healthtech, AI, and consumer services.
About Samsung Next
Samsung Next is the venture and innovation arm of Samsung focused on consumer software, AI, and digital platforms, including selectively digital health, mental health, and consumer wellness products that align with Samsung’s device and platform strategy. Stage focus is seed through Series B, with checks plausibly in the $1M to $10M range depending on stage. Healthcare exposure is opportunistic and concentrated in consumer-facing digital health, mental health, and wellness platforms rather than therapeutics, devices, or hospital-side enterprise software. Physician founders building consumer mental health platforms, wellness apps with credible engagement and retention signals, or digital health products with Samsung device or platform alignment are the right profile. Founders building therapeutics, B2B hospital software, or capital-intensive devices should pitch elsewhere. Geographic posture is global, with active deal capacity in North America, Europe, and Israel. The realistic entry path is a warm introduction from a Samsung Next portfolio CEO, a co-investing seed or Series A fund, or a Samsung product team contact; the partners are responsive and the process is generally founder-friendly. Founders should arrive with consumer-grade engagement metrics, retention math, and an articulated product narrative. Treat Samsung Next as a strategic consumer-tech partner with platform distribution insight, particularly relevant for digital health founders building consumer-pull products that align with the broader Samsung ecosystem.
Founder reviews
Healthcare AI tools backed by Samsung Next
Tools made by companies in Samsung Next's portfolio that we cover in the directory.
Portfolio companies in our directory
Other portfolio companies
Companies in Samsung Next's portfolio not currently in our directory.
- Huma · 2021
- Better Health · 2024
- Nucleus Genomics · 2026
- NeuraLight · 2022
- Alpha Medical · 2021
- Redesign Health · 2022
- Centaur Labs · 2024
Team
Pitch / review this investor
Have you raised from Samsung Next? Founders only — share your honest experience (anonymous OK, moderated before publishing).






